Anand Mehra Insider Trading $ONCE Spark Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anand Mehra.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anand Mehra. Anand Mehra is 10% Owner in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in AERIE PHARMACEUTICALS INC ($AERI) and Director in Aclaris Therapeutics, Inc. ($ACRS) and Director in Spark Therapeutics, Inc. ($ONCE).
Anand Mehra in Spark Therapeutics, Inc.
Trading Symbol: ONCEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anand Mehra: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Anand Mehra in Spark Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AERI, MRNS, ONCE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 481,270 | 55,105,415 | 0 | 481.3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 481,270 | 55,105,415 | 0 | 481.3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 40,203 | 4,603,244 | 0 | 40.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 40,203 | 4,603,244 | 0 | 40.2 K to 0 (-100.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Buy | M | 0.00 | 1,500 | 0 | 40,203 | 38.7 K to 40.2 K (+3.88 %) |
Jan 08 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | M | 3.45 | 37,203 | 128,350 | 0 | |
Jan 08 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Buy | M | 3.45 | 37,203 | 128,350 | 38,703 | 1.5 K to 38.7 K (+2,480.20 %) |
Jun 01 2018 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 01 2018 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
Jun 01 2018 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
Jun 01 2018 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Buy | M | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
Jul 26 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 73.10 | 518 | 37,866 | 481,270 | 481.8 K to 481.3 K (-0.11 %) |
Jul 26 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 72.28 | 4,679 | 338,198 | 481,788 | 486.5 K to 481.8 K (-0.96 %) |
Jul 26 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 71.59 | 7,350 | 526,187 | 486,467 | 493.8 K to 486.5 K (-1.49 %) |
Jul 26 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 70.04 | 199,311 | 13,959,742 | 493,817 | 693.1 K to 493.8 K (-28.76 %) |
Jun 22 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.00 | 5,282 | 343,330 | 693,128 | 698.4 K to 693.1 K (-0.76 %) |
Jun 22 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.00 | 1,020 | 66,300 | 698,410 | 699.4 K to 698.4 K (-0.15 %) |
Mar 06 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.01 | 15,275 | 993,028 | 699,430 | 714.7 K to 699.4 K (-2.14 %) |
Mar 01 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.01 | 17,470 | 1,135,725 | 714,705 | 732.2 K to 714.7 K (-2.39 %) |
Mar 01 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.02 | 25,274 | 1,643,315 | 732,175 | 757.4 K to 732.2 K (-3.34 %) |
Mar 01 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.02 | 41,910 | 2,724,988 | 757,449 | 799.4 K to 757.4 K (-5.24 %) |
Feb 22 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.01 | 7,535 | 489,850 | 799,359 | 806.9 K to 799.4 K (-0.93 %) |
Feb 16 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.01 | 2,900 | 188,529 | 806,894 | 809.8 K to 806.9 K (-0.36 %) |
Feb 16 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.03 | 31,497 | 2,048,250 | 809,794 | 841.3 K to 809.8 K (-3.74 %) |
Feb 16 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.02 | 950 | 61,769 | 841,291 | 842.2 K to 841.3 K (-0.11 %) |
Feb 13 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.06 | 37,411 | 2,433,960 | 842,241 | 879.7 K to 842.2 K (-4.25 %) |
Feb 07 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.04 | 1,994 | 129,690 | 879,652 | 881.6 K to 879.7 K (-0.23 %) |
Feb 07 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.00 | 1,010 | 65,650 | 881,646 | 882.7 K to 881.6 K (-0.11 %) |
Feb 07 2017 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 65.06 | 22,330 | 1,452,790 | 882,656 | 905 K to 882.7 K (-2.47 %) |
Dec 19 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 54.91 | 50,000 | 2,745,500 | 904,986 | 955 K to 905 K (-5.24 %) |
Dec 19 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 53.26 | 229,728 | 12,235,313 | 954,986 | 1.2 M to 955 K (-19.39 %) |
Dec 19 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 53.07 | 69,928 | 3,711,079 | 1,184,714 | 1.3 M to 1.2 M (-5.57 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 53.32 | 22,281 | 1,188,023 | 1,254,642 | 1.3 M to 1.3 M (-1.74 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 57.24 | 33,840 | 1,937,002 | 1,276,923 | 1.3 M to 1.3 M (-2.58 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 56.55 | 10,900 | 616,395 | 1,310,763 | 1.3 M to 1.3 M (-0.82 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 55.27 | 22,113 | 1,222,186 | 1,321,663 | 1.3 M to 1.3 M (-1.65 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 54.03 | 24,498 | 1,323,627 | 1,343,776 | 1.4 M to 1.3 M (-1.79 %) |
Dec 13 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 53.07 | 8,900 | 472,323 | 1,368,274 | 1.4 M to 1.4 M (-0.65 %) |
Aug 12 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 61.48 | 500 | 30,740 | 1,377,174 | 1.4 M to 1.4 M (-0.04 %) |
Aug 12 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.14 | 22,563 | 1,356,939 | 1,377,674 | 1.4 M to 1.4 M (-1.61 %) |
Aug 12 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.02 | 6,900 | 414,138 | 1,400,237 | 1.4 M to 1.4 M (-0.49 %) |
Aug 10 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.47 | 100 | 6,047 | 1,407,137 | 1.4 M to 1.4 M (-0.01 %) |
Aug 05 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.00 | 452 | 27,120 | 1,407,237 | 1.4 M to 1.4 M (-0.03 %) |
Aug 05 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.00 | 4,612 | 276,720 | 1,407,689 | 1.4 M to 1.4 M (-0.33 %) |
Aug 03 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.03 | 22,665 | 1,360,580 | 1,412,301 | 1.4 M to 1.4 M (-1.58 %) |
Jun 03 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | A | 56.22 | 6,000 | 337,320 | 6,000 | |
Jun 02 2016 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.00 | 500 | 30,000 | 1,434,966 | 1.4 M to 1.4 M (-0.03 %) |
Nov 30 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.02 | 5,350 | 321,107 | 1,435,466 | 1.4 M to 1.4 M (-0.37 %) |
Nov 30 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.01 | 17,611 | 1,056,836 | 1,440,816 | 1.5 M to 1.4 M (-1.21 %) |
Nov 12 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.00 | 1,074 | 64,440 | 1,458,427 | 1.5 M to 1.5 M (-0.07 %) |
Nov 12 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.13 | 97,644 | 5,871,334 | 1,459,501 | 1.6 M to 1.5 M (-6.27 %) |
Nov 12 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.01 | 5,932 | 355,979 | 1,557,145 | 1.6 M to 1.6 M (-0.38 %) |
Nov 12 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 60.07 | 25,955 | 1,559,117 | 1,563,077 | 1.6 M to 1.6 M (-1.63 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 46.38 | 11,316 | 524,836 | 1,589,032 | 1.6 M to 1.6 M (-0.71 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 45.27 | 145,723 | 6,596,880 | 1,600,348 | 1.7 M to 1.6 M (-8.35 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 44.38 | 120,593 | 5,351,917 | 1,746,071 | 1.9 M to 1.7 M (-6.46 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 47.14 | 13,402 | 631,770 | 1,866,664 | 1.9 M to 1.9 M (-0.71 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 46.23 | 153,008 | 7,073,560 | 1,880,066 | 2 M to 1.9 M (-7.53 %) |
Oct 09 2015 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | S | 45.56 | 85,502 | 3,895,471 | 2,033,074 | 2.1 M to 2 M (-4.04 %) |
Page: 1